ID   UBE2K_HUMAN             Reviewed;         200 AA.
AC   P61086; A6NJC1; A8K5Y9; B2RDF8; C9JGP1; O54806; P27924; Q16721;
AC   Q9CVV9; Q9Y2D3;
DT   26-APR-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   10-MAY-2017, entry version 150.
DE   RecName: Full=Ubiquitin-conjugating enzyme E2 K;
DE            EC=2.3.2.23 {ECO:0000269|PubMed:20061386};
DE   AltName: Full=E2 ubiquitin-conjugating enzyme K;
DE   AltName: Full=Huntingtin-interacting protein 2;
DE            Short=HIP-2;
DE   AltName: Full=Ubiquitin carrier protein;
DE   AltName: Full=Ubiquitin-conjugating enzyme E2-25 kDa;
DE            Short=Ubiquitin-conjugating enzyme E2(25K);
DE            Short=Ubiquitin-conjugating enzyme E2-25K;
DE   AltName: Full=Ubiquitin-protein ligase;
GN   Name=UBE2K; Synonyms=HIP2, LIG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8702625; DOI=10.1074/jbc.271.32.19385;
RA   Kalchman M.A., Graham R.K., Xia G., Koide H.B., Hodgson J.G.,
RA   Graham K.C., Goldberg Y.P., Gietz R.D., Pickart C.M., Hayden M.R.;
RT   "Huntingtin is ubiquitinated and interacts with a specific ubiquitin-
RT   conjugating enzyme.";
RL   J. Biol. Chem. 271:19385-19394(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=10634809; DOI=10.1161/01.ATV.20.1.128;
RA   Kikuchi J., Furukawa Y., Kubo N., Tokura A., Hayashi N., Nakamura M.,
RA   Matsuda M., Sakurabayashi I.;
RT   "Induction of ubiquitin-conjugating enzyme by aggregated low density
RT   lipoprotein in human macrophages and its implications for
RT   atherosclerosis.";
RL   Arterioscler. Thromb. Vasc. Biol. 20:128-134(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, TISSUE
RP   SPECIFICITY, AND INDUCTION.
RX   PubMed=10675012;
RX   DOI=10.1002/(SICI)1522-2683(20000101)21:2<338::AID-ELPS338>3.0.CO;2-9;
RA   Furukawa Y., Kubo N., Kikuchi J., Tokura A., Fujita N.,
RA   Sakurabayashi I.;
RT   "Regulation of macrophage-specific gene expression by degenerated
RT   lipoproteins.";
RL   Electrophoresis 21:338-346(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H.,
RA   Minx P., Wagner-McPherson C., Layman D., Wylie K., Sekhon M.,
RA   Becker M.C., Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E.,
RA   Kremitzki C., Oddy L., Du H., Sun H., Bradshaw-Cordum H., Ali J.,
RA   Carter J., Cordes M., Harris A., Isak A., van Brunt A., Nguyen C.,
RA   Du F., Courtney L., Kalicki J., Ozersky P., Abbott S., Armstrong J.,
RA   Belter E.A., Caruso L., Cedroni M., Cotton M., Davidson T., Desai A.,
RA   Elliott G., Erb T., Fronick C., Gaige T., Haakenson W., Haglund K.,
RA   Holmes A., Harkins R., Kim K., Kruchowski S.S., Strong C.M.,
RA   Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N.,
RA   Swearengen-Shahid S., Snider J., Strong J.T., Thompson J., Yoakum M.,
RA   Leonard S., Pearman C., Trani L., Radionenko M., Waligorski J.E.,
RA   Wang C., Rock S.M., Tin-Wollam A.-M., Maupin R., Latreille P.,
RA   Wendl M.C., Yang S.-P., Pohl C., Wallis J.W., Spieth J., Bieri T.A.,
RA   Berkowicz N., Nelson J.O., Osborne J., Ding L., Meyer R., Sabo A.,
RA   Shotland Y., Sinha P., Wohldmann P.E., Cook L.L., Hickenbotham M.T.,
RA   Eldred J., Williams D., Jones T.A., She X., Ciccarelli F.D.,
RA   Izaurralde E., Taylor J., Schmutz J., Myers R.M., Cox D.R., Huang X.,
RA   McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D.,
RA   Waterston R.H., Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2
RT   and 4.";
RL   Nature 434:724-731(2005).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   PROTEIN SEQUENCE OF 2-10; 62-72; 79-97 AND 166-186, FUNCTION,
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH RNF138.
RX   PubMed=16714285; DOI=10.1074/jbc.M602089200;
RA   Yamada M., Ohnishi J., Ohkawara B., Iemura S., Satoh K.,
RA   Hyodo-Miura J., Kawachi K., Natsume T., Shibuya H.;
RT   "NARF, an nemo-like kinase (NLK)-associated ring finger protein
RT   regulates the ubiquitylation and degradation of T cell factor/lymphoid
RT   enhancer factor (TCF/LEF).";
RL   J. Biol. Chem. 281:20749-20760(2006).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A.,
RA   Thomas G.R., Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass
RT   spectrometric identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [11]
RP   PROTEIN SEQUENCE OF 2-8; 56-72 AND 177-186, CLEAVAGE OF INITIATOR
RP   METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma;
RA   Bienvenut W.V., Bilsland A.E., Keith W.N.;
RL   Submitted (JAN-2010) to UniProtKB.
RN   [12]
RP   FUNCTION IN DEGRADATION OF MHC CLASS I HEAVY CHAINS.
RX   PubMed=16868077; DOI=10.1073/pnas.0605215103;
RA   Flierman D., Coleman C.S., Pickart C.M., Rapoport T.A., Chau V.;
RT   "E2-25K mediates US11-triggered retro-translocation of MHC class I
RT   heavy chains in a permeabilized cell system.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:11589-11594(2006).
RN   [13]
RP   FUNCTION IN POLYUBIQUITINATION, AND INTERACTION WITH BRCA1.
RX   PubMed=17873885; DOI=10.1038/nsmb1295;
RA   Christensen D.E., Brzovic P.S., Klevit R.E.;
RT   "E2-BRCA1 RING interactions dictate synthesis of mono- or specific
RT   polyubiquitin chain linkages.";
RL   Nat. Struct. Mol. Biol. 14:941-948(2007).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-14, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M.,
RA   Walther T.C., Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [15]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=20061386; DOI=10.1074/jbc.M109.089003;
RA   David Y., Ziv T., Admon A., Navon A.;
RT   "The E2 ubiquitin-conjugating enzymes direct polyubiquitination to
RT   preferred lysines.";
RL   J. Biol. Chem. 285:8595-8604(2010).
RN   [16]
RP   FUNCTION IN VIRUS-INDUCED DEGRADATION OF RB1.
RX   PubMed=19906396; DOI=10.1016/j.virol.2009.10.018;
RA   Oh K.J., Kalinina A., Bagchi S.;
RT   "Destabilization of Rb by human papillomavirus E7 is cell cycle
RT   dependent: E2-25K is involved in the proteolysis.";
RL   Virology 396:118-124(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   MUTAGENESIS OF ASP-94.
RX   PubMed=21532592; DOI=10.1038/nature09966;
RA   Wenzel D.M., Lissounov A., Brzovic P.S., Klevit R.E.;
RT   "UBCH7 reactivity profile reveals parkin and HHARI to be RING/HECT
RT   hybrids.";
RL   Nature 474:105-108(2011).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C.,
RA   Meinnel T., Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [20]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E.,
RA   Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K.,
RA   Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-
RT   terminal acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-14, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M.,
RA   Ayoub D., Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS).
RX   PubMed=19407372; DOI=10.1107/S1744309109011117;
RA   Wilson R.C., Hughes R.C., Flatt J.W., Meehan E.J., Ng J.D.,
RA   Twigg P.D.;
RT   "Structure of full-length ubiquitin-conjugating enzyme E2-25K
RT   (Huntingtin-interacting protein 2).";
RL   Acta Crystallogr. F 65:440-444(2009).
RN   [25]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEX WITH UBE2I.
RG   Structural genomics consortium (SGC);
RT   "A novel and unexpected complex between the SUMO-1-conjugating enzyme
RT   UBC9 and the ubiquitin-conjugating enzyme E2-25 kDA.";
RL   Submitted (FEB-2009) to the PDB data bank.
RN   [26]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS).
RG   Structural genomics consortium (SGC);
RT   "Ubiquitin-conjugating enzyme E2-25 kDA (Huntington-interacting
RT   protein 2).";
RL   Submitted (FEB-2009) to the PDB data bank.
CC   -!- FUNCTION: Accepts ubiquitin from the E1 complex and catalyzes its
CC       covalent attachment to other proteins. In vitro, in the presence
CC       or in the absence of BRCA1-BARD1 E3 ubiquitin-protein ligase
CC       complex, catalyzes the synthesis of 'Lys-48'-linked polyubiquitin
CC       chains. Does not transfer ubiquitin directly to but elongates
CC       monoubiquitinated substrate protein. Mediates the selective
CC       degradation of short-lived and abnormal proteins, such as the
CC       endoplasmic reticulum-associated degradation (ERAD) of misfolded
CC       lumenal proteins. Ubiquitinates huntingtin. May mediate foam cell
CC       formation by the suppression of apoptosis of lipid-bearing
CC       macrophages through ubiquitination and subsequence degradation of
CC       p53/TP53. Proposed to be involved in ubiquitination and
CC       proteolytic processing of NF-kappa-B; in vitro supports
CC       ubiquitination of NFKB1. In case of infection by cytomegaloviruses
CC       may be involved in the US11-dependent degradation of MHC class I
CC       heavy chains following their export from the ER to the cytosol. In
CC       case of viral infections may be involved in the HPV E7 protein-
CC       dependent degradation of RB1. {ECO:0000269|PubMed:10634809,
CC       ECO:0000269|PubMed:10675012, ECO:0000269|PubMed:16714285,
CC       ECO:0000269|PubMed:16868077, ECO:0000269|PubMed:17873885,
CC       ECO:0000269|PubMed:19906396, ECO:0000269|PubMed:20061386,
CC       ECO:0000269|PubMed:8702625}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E1 ubiquitin-activating
CC       enzyme]-L-cysteine + [E2 ubiquitin-conjugating enzyme]-L-cysteine
CC       = [E1 ubiquitin-activating enzyme]-L-cysteine + S-ubiquitinyl-[E2
CC       ubiquitin-conjugating enzyme]-L-cysteine. {ECO:0000255|PROSITE-
CC       ProRule:PRU00388, ECO:0000255|PROSITE-ProRule:PRU10133,
CC       ECO:0000269|PubMed:20061386}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -!- SUBUNIT: Interacts with RNF138/NARF. Interacts with BRCA1.
CC       {ECO:0000269|PubMed:16714285, ECO:0000269|PubMed:17873885,
CC       ECO:0000269|Ref.25}.
CC   -!- INTERACTION:
CC       P14635:CCNB1; NbExp=2; IntAct=EBI-473850, EBI-495332;
CC       Q8WTU0:DDI1; NbExp=3; IntAct=EBI-473850, EBI-748248;
CC       Q8N9I9:DTX3; NbExp=5; IntAct=EBI-473850, EBI-2340258;
CC       P42858:HTT; NbExp=3; IntAct=EBI-473850, EBI-466029;
CC       Q8TD10:MIPOL1; NbExp=5; IntAct=EBI-473850, EBI-2548751;
CC       Q99PZ6:ospG (xeno); NbExp=2; IntAct=EBI-473850, EBI-9316527;
CC       Q04864:REL; NbExp=3; IntAct=EBI-473850, EBI-307352;
CC       Q8WVD3:RNF138; NbExp=7; IntAct=EBI-473850, EBI-749039;
CC       Q99942:RNF5; NbExp=5; IntAct=EBI-473850, EBI-348482;
CC       Q8IUQ4:SIAH1; NbExp=4; IntAct=EBI-473850, EBI-747107;
CC       P14373:TRIM27; NbExp=8; IntAct=EBI-473850, EBI-719493;
CC       Q9HCM9:TRIM39; NbExp=3; IntAct=EBI-473850, EBI-739510;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:P61085}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P61086-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P61086-2; Sequence=VSP_011798;
CC         Note=May be inactive.;
CC       Name=3;
CC         IsoId=P61086-3; Sequence=VSP_046211;
CC         Note=No experimental confirmation available.;
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested, including
CC       spleen, thymus, prostate, testis, ovary, small intestine, colon,
CC       peripheral blood leukocytes, T-lymphocytes, monocytes,
CC       granulocytes and bone marrow mononuclear cells. Highly expressed
CC       in brain, with highest levels found in cortex and striatum and at
CC       lower levels in cerebellum and brainstem.
CC       {ECO:0000269|PubMed:10634809, ECO:0000269|PubMed:10675012,
CC       ECO:0000269|PubMed:8702625}.
CC   -!- INDUCTION: By aggregated low-density lipoprotein.
CC       {ECO:0000269|PubMed:10634809, ECO:0000269|PubMed:10675012}.
CC   -!- PTM: Sumoylation at Lys-14 impairs catalytic activity.
CC       {ECO:0000250|UniProtKB:P61085}.
CC   -!- SIMILARITY: Belongs to the ubiquitin-conjugating enzyme family.
CC       {ECO:0000255|PROSITE-ProRule:PRU00388}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; U58522; AAC50633.1; -; mRNA.
DR   EMBL; AB022435; BAA78555.1; -; mRNA.
DR   EMBL; AB022436; BAA78556.1; -; mRNA.
DR   EMBL; BX339118; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK291454; BAF84143.1; -; mRNA.
DR   EMBL; AK315524; BAG37905.1; -; mRNA.
DR   EMBL; AC105287; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108471; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471069; EAW92948.1; -; Genomic_DNA.
DR   EMBL; BC022804; AAH22804.1; -; mRNA.
DR   EMBL; BC050600; AAH50600.1; -; mRNA.
DR   CCDS; CCDS33976.1; -. [P61086-1]
DR   CCDS; CCDS47043.1; -. [P61086-3]
DR   CCDS; CCDS47044.1; -. [P61086-2]
DR   RefSeq; NP_001104582.1; NM_001111112.1. [P61086-3]
DR   RefSeq; NP_001104583.1; NM_001111113.1. [P61086-2]
DR   RefSeq; NP_005330.1; NM_005339.4. [P61086-1]
DR   UniGene; Hs.50308; -.
DR   PDB; 1YLA; X-ray; 2.40 A; A/B=1-200.
DR   PDB; 2O25; X-ray; 2.60 A; A/B=1-200.
DR   PDB; 3E46; X-ray; 1.86 A; A=1-200.
DR   PDB; 3F92; X-ray; 2.23 A; A=13-200.
DR   PDB; 3K9O; X-ray; 1.80 A; A=1-200.
DR   PDB; 3K9P; X-ray; 2.80 A; A=1-200.
DR   PDB; 5DFL; X-ray; 2.10 A; A=1-200.
DR   PDBsum; 1YLA; -.
DR   PDBsum; 2O25; -.
DR   PDBsum; 3E46; -.
DR   PDBsum; 3F92; -.
DR   PDBsum; 3K9O; -.
DR   PDBsum; 3K9P; -.
DR   PDBsum; 5DFL; -.
DR   ProteinModelPortal; P61086; -.
DR   SMR; P61086; -.
DR   BioGrid; 109340; 92.
DR   DIP; DIP-32524N; -.
DR   IntAct; P61086; 40.
DR   MINT; MINT-5000019; -.
DR   STRING; 9606.ENSP00000261427; -.
DR   iPTMnet; P61086; -.
DR   PhosphoSitePlus; P61086; -.
DR   SwissPalm; P61086; -.
DR   BioMuta; UBE2K; -.
DR   DMDM; 46577658; -.
DR   OGP; P27924; -.
DR   EPD; P61086; -.
DR   MaxQB; P61086; -.
DR   PaxDb; P61086; -.
DR   PeptideAtlas; P61086; -.
DR   PRIDE; P61086; -.
DR   TopDownProteomics; P61086-1; -. [P61086-1]
DR   DNASU; 3093; -.
DR   Ensembl; ENST00000261427; ENSP00000261427; ENSG00000078140. [P61086-1]
DR   Ensembl; ENST00000445950; ENSP00000390483; ENSG00000078140. [P61086-3]
DR   Ensembl; ENST00000503368; ENSP00000421203; ENSG00000078140. [P61086-2]
DR   GeneID; 3093; -.
DR   KEGG; hsa:3093; -.
DR   UCSC; uc003gus.5; human. [P61086-1]
DR   CTD; 3093; -.
DR   DisGeNET; 3093; -.
DR   GeneCards; UBE2K; -.
DR   HGNC; HGNC:4914; UBE2K.
DR   HPA; CAB033212; -.
DR   HPA; CAB033515; -.
DR   HPA; HPA028869; -.
DR   MIM; 602846; gene.
DR   neXtProt; NX_P61086; -.
DR   OpenTargets; ENSG00000078140; -.
DR   PharmGKB; PA162407874; -.
DR   eggNOG; KOG0418; Eukaryota.
DR   eggNOG; COG5078; LUCA.
DR   GeneTree; ENSGT00670000098059; -.
DR   HOGENOM; HOG000233455; -.
DR   HOVERGEN; HBG063308; -.
DR   InParanoid; P61086; -.
DR   KO; K04649; -.
DR   OMA; HEMFILT; -.
DR   OrthoDB; EOG091G0KVW; -.
DR   PhylomeDB; P61086; -.
DR   TreeFam; TF101127; -.
DR   BRENDA; 2.3.2.B6; 2681.
DR   Reactome; R-HSA-8866652; Synthesis of active ubiquitin: roles of E1 and E2 enzymes.
DR   Reactome; R-HSA-936440; Negative regulators of RIG-I/MDA5 signaling.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; P61086; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; UBE2K; human.
DR   EvolutionaryTrace; P61086; -.
DR   GeneWiki; HIP2; -.
DR   GenomeRNAi; 3093; -.
DR   PRO; PR:P61086; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   Bgee; ENSG00000078140; -.
DR   CleanEx; HS_UBE2K; -.
DR   ExpressionAtlas; P61086; baseline and differential.
DR   Genevisible; P61086; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0034450; F:ubiquitin-ubiquitin ligase activity; IDA:UniProtKB.
DR   GO; GO:0035458; P:cellular response to interferon-beta; IMP:UniProtKB.
DR   GO; GO:0010994; P:free ubiquitin chain polymerization; IDA:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0010800; P:positive regulation of peptidyl-threonine phosphorylation; IDA:UniProtKB.
DR   GO; GO:0060340; P:positive regulation of type I interferon-mediated signaling pathway; IMP:UniProtKB.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IBA:GO_Central.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0032434; P:regulation of proteasomal ubiquitin-dependent protein catabolic process; IEA:Ensembl.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; TAS:ProtInc.
DR   CDD; cd00195; UBCc; 1.
DR   Gene3D; 3.10.110.10; -; 1.
DR   InterPro; IPR015940; UBA.
DR   InterPro; IPR009060; UBA-like.
DR   InterPro; IPR000608; UBQ-conjugat_E2.
DR   InterPro; IPR023313; UBQ-conjugating_AS.
DR   InterPro; IPR016135; UBQ-conjugating_enzyme/RWD.
DR   Pfam; PF00627; UBA; 1.
DR   Pfam; PF00179; UQ_con; 1.
DR   SMART; SM00165; UBA; 1.
DR   SUPFAM; SSF46934; SSF46934; 1.
DR   SUPFAM; SSF54495; SSF54495; 1.
DR   PROSITE; PS50030; UBA; 1.
DR   PROSITE; PS00183; UBIQUITIN_CONJUGAT_1; 1.
DR   PROSITE; PS50127; UBIQUITIN_CONJUGAT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Complete proteome; Cytoplasm; Direct protein sequencing;
KW   Isopeptide bond; Nucleotide-binding; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway.
FT   INIT_MET      1      1       Removed. {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|PubMed:12665801,
FT                                ECO:0000269|PubMed:16714285,
FT                                ECO:0000269|Ref.11}.
FT   CHAIN         2    200       Ubiquitin-conjugating enzyme E2 K.
FT                                /FTId=PRO_0000082443.
FT   DOMAIN      160    200       UBA. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00212}.
FT   ACT_SITE     92     92       Glycyl thioester intermediate.
FT                                {ECO:0000255|PROSITE-ProRule:PRU00388,
FT                                ECO:0000255|PROSITE-ProRule:PRU10133}.
FT   MOD_RES       2      2       N-acetylalanine.
FT                                {ECO:0000244|PubMed:22223895,
FT                                ECO:0000244|PubMed:22814378,
FT                                ECO:0000269|Ref.11}.
FT   MOD_RES      14     14       N6-acetyllysine; alternate.
FT                                {ECO:0000244|PubMed:19608861}.
FT   MOD_RES     159    159       Phosphoserine.
FT                                {ECO:0000244|PubMed:23186163}.
FT   CROSSLNK     14     14       Glycyl lysine isopeptide (Lys-Gly)
FT                                (interchain with G-Cter in SUMO1);
FT                                alternate. {ECO:0000244|PubMed:25114211}.
FT   VAR_SEQ      22     72       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:10634809,
FT                                ECO:0000303|PubMed:10675012,
FT                                ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_011798.
FT   VAR_SEQ     134    176       Missing (in isoform 3).
FT                                {ECO:0000303|Ref.4}.
FT                                /FTId=VSP_046211.
FT   MUTAGEN      94     94       D->E: Decreased lysine reactivity and
FT                                impaired formation of free polyubiquitin
FT                                chains. {ECO:0000269|PubMed:21532592}.
FT   HELIX         6     17       {ECO:0000244|PDB:3K9O}.
FT   HELIX        20     23       {ECO:0000244|PDB:3K9O}.
FT   STRAND       26     31       {ECO:0000244|PDB:3K9O}.
FT   STRAND       33     35       {ECO:0000244|PDB:2O25}.
FT   STRAND       36     44       {ECO:0000244|PDB:3K9O}.
FT   STRAND       47     49       {ECO:0000244|PDB:1YLA}.
FT   TURN         50     53       {ECO:0000244|PDB:3K9O}.
FT   STRAND       55     61       {ECO:0000244|PDB:3K9O}.
FT   TURN         64     68       {ECO:0000244|PDB:3K9O}.
FT   STRAND       72     77       {ECO:0000244|PDB:3K9O}.
FT   TURN         86     88       {ECO:0000244|PDB:3K9O}.
FT   HELIX        94     96       {ECO:0000244|PDB:3K9O}.
FT   TURN         97     99       {ECO:0000244|PDB:3K9O}.
FT   HELIX       106    118       {ECO:0000244|PDB:3K9O}.
FT   HELIX       128    136       {ECO:0000244|PDB:3K9O}.
FT   HELIX       138    153       {ECO:0000244|PDB:3K9O}.
FT   HELIX       160    170       {ECO:0000244|PDB:3K9O}.
FT   TURN        171    173       {ECO:0000244|PDB:3K9O}.
FT   HELIX       176    185       {ECO:0000244|PDB:3K9O}.
FT   TURN        186    188       {ECO:0000244|PDB:3K9O}.
FT   HELIX       190    199       {ECO:0000244|PDB:3K9O}.
SQ   SEQUENCE   200 AA;  22407 MW;  E40668099ED25828 CRC64;
     MANIAVQRIK REFKEVLKSE ETSKNQIKVD LVDENFTELR GEIAGPPDTP YEGGRYQLEI
     KIPETYPFNP PKVRFITKIW HPNISSVTGA ICLDILKDQW AAAMTLRTVL LSLQALLAAA
     EPDDPQDAVV ANQYKQNPEM FKQTARLWAH VYAGAPVSSP EYTKKIENLC AMGFDRNAVI
     VALSSKSWDV ETATELLLSN
//
